K. Br�sen

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

K. Br�sen, L. F. Gram · European Journal of Clinical Pharmacology · 1989 · 285 citations

Mendelian Disorder, Sparteine/debrisoquine Oxidation Polymorphism, Genetics +4

Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine

K. Br�sen, J G Hansen, Karin Kramer Nielsen et al. · European Journal of Clinical Pharmacology · 1993 · 193 citations

Pharmacological Study, Biochemistry, Medicine +8

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

Søren H. Sindrup, Bent Ejlertsen, A. Fr�land et al. · European Journal of Clinical Pharmacology · 1989 · 105 citations

Imipramine Treatment, Pain Medicine, Medicine +7

The effect of quinidine on the analgesic effect of codeine

Søren H. Sindrup, Lars Arendt‐Nielsen, K. Br�sen et al. · European Journal of Clinical Pharmacology · 1992 · 95 citations

Analgesic Effect, Health Sciences, Pain Medicine +9

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

Tanja Busk Bidstrup, Nicolaj M. Stilling, Per Damkier et al. · European Journal of Clinical Pharmacology · 2004 · 83 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +9